Professor Veronique Gouverneur, FRS, EurASc Fellow, University of Oxford, UK, received the 2021 Moissan International Prize commemorating the isolation of elemental fluorine by Henri Moissan and stimulating research in the fields of fluorine chemistry.
This Prize, which is given every three years by the “Fondation de la Maison de la Chimie” in Paris rewards a researcher of international stature who has obtained exceptional results in the fields of fluorine and fluorinated products.
Professor Giorgio Parisi, from the University “La Sapienza” in Roma, is one of the winners of the Nobel Prize in Physics for “for the discovery of the interplay of disorder and fluctuations in physical systems from atomic to planetary scales”.
Mr. Jean-Eric Paquet, European Commission, Director-General, DG Research and Innovation Horizon Europe FP9
10:30
Pr. Elias Fattal, University Paris-Orsay, Pharmacy Faculty, Galien Institute Nanomedicine for tackling physiological resistances to drug delivery
11:10
Pr. Stefaan de Smet, Ghent University, EURASC Physico-Chemistry of nanoparticles for drug delivery
11:50
Dr. Carine Giovannangeli, CNRS – National Museum of Natural History Genome modification and gene editing
12:30
Pause
14:00
Dr. Ana Buj-Bello, Généthon Laboratory, Inserm Gene therapy of neuromuscular disorders with viral-derived vectors
14:40
Pr. Daniel Scherman, Foundation for Rare Diseases, Pharmacy Faculty, Paris University, CNRS, Inserm, EURASC Genetic Pharmacology: RNA-silencing nanoparticles and targeted nanodrugs for rare diseases
15:20
Pr. Odile Launay, Haut Conseil de la Santé Publique, Professor of Infectiology Hôpital Cochin-Broca-Hôtel-Dieu Strategies of COVID-19 vaccination
16:00
Pr. Neil Ferguson, Imperial College, London Modelling of the Covid-19 pandemic. Connections with computational science, mathematical epidemiology, and control and vaccination policy making
16:40
Pr. Alain Fischer, Imagine Institute, Necker Hospital, French Academy of Sciences and Academy of Medicine Gene therapy of severe immune rare diseases
17:20
Dr. Hervé Chneiweiss Inserm, Président od Inserm Ethics Committee and of CCNE (Comité Consultatif National d’Ethique pour les sciences de la vie et de la santé) Ethical considerations in Biomedicine